Brussels, Belgium

Lionel Sansoe

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Lionel Sansoe in Drug Delivery Systems

Introduction

Lionel Sansoe is an innovative inventor based in Brussels, Belgium. He has made significant contributions to the field of drug delivery systems, particularly with his work on self-microemulsifying compositions. His inventions aim to enhance the bioavailability of important medications, showcasing his commitment to improving healthcare solutions.

Latest Patents

Lionel Sansoe holds a patent for a self-microemulsifying drug delivery system (SMEDDS) of mitotane. This invention relates to a mitotane oily formulation that comprises propylene glycol monocaprylate (10 to 30% w/w), propylene glycol dicaprate (20 to 60% w/w), and polyoxyethylenesorbitanne monooleate (10 to 30% w/w). This innovative formulation is designed to improve the bioavailability of mitotane, making it more effective for patients.

Career Highlights

Throughout his career, Lionel Sansoe has focused on developing advanced drug delivery systems. His work has been recognized for its potential to transform the way medications are administered and absorbed in the body. With a patent portfolio that includes 1 patent, he continues to push the boundaries of pharmaceutical technology.

Collaborations

Lionel has collaborated with notable professionals in his field, including Florian Battung and Emad Hassan. These partnerships have allowed him to enhance his research and development efforts, leading to innovative solutions in drug delivery.

Conclusion

Lionel Sansoe's contributions to the field of drug delivery systems exemplify his dedication to innovation and improving patient care. His patented work on self-microemulsifying compositions highlights the importance of enhancing drug bioavailability.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…